McNair v. Johnson & Johnson

There is no cause of action in West Virginia for failure to warn and negligent misrepresentation against a branded drug manufacturer when the drug ingested was produced by a generic manufacturer. Petitioners, Kimmy and Larry McNair, filed an action against Respondent, Janssen Pharmaceuticals, alleging that Kimmy developed acute respiratory distress after ingestion the generic drug levofloxacin that was manufactured by Dr. Reddy’s Laboraties Limited. Janssen originally trademarked and sold levofloxacin under the brand Levaquin and produced the warnings on the label that accompanied the distribution of the drug, which were subsequently used by generic manufacturers of levofloxacin. The McNairs alleged that Janssen had exclusive control of the content of the warning for both the brand-name and generic forms of the drug and was therefore liable for their alleged injuries. The federal district court granted summary judgment to Janssen, finding that because Janssen did not manufacture the product ingested by Kimmy, there was no basis on which to hold Janssen liable. On appeal, the Fourth Circuit Court of Appeals certified to the Supreme Court a question of law. In answering as set forth above, the Supreme Court declined to expand its products liability law. View "McNair v. Johnson & Johnson" on Justia Law